Yunfeng Zhao Selected Research

Yunfeng Zhao Research Topics

Disease

48	Neoplasms (Cancer) 11/2023 - 09/2002
18	Carcinogenesis 10/2022 - 01/2003
10	Body Weight (Weight, Body) 03/2022 - 10/2005
7	Acute Lung Injury 01/2022 - 01/2011
6	Inflammation (Inflammations) 12/2021 - 01/2009
6	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 01/2018
5	Pulmonary Embolism 11/2023 - 06/2017
5	Pulmonary Edema 01/2022 - 10/2015
5	Melanoma (Melanoma, Malignant) 01/2020 - 05/2008
4	Papillary Thyroid Cancer 11/2023 - 11/2018
4	Hypertension (High Blood Pressure) 06/2023 - 05/2018
4	Lung Neoplasms (Lung Cancer) 12/2021 - 06/2017
4	Skin Neoplasms (Skin Cancer) 01/2018 - 01/2011
4	Breast Neoplasms (Breast Cancer) 06/2015 - 04/2006
3	Lung Injury 01/2022 - 02/2016
3	Hypoxia (Hypoxemia) 10/2019 - 11/2017
2	Type 2 Diabetes Mellitus (MODY) 02/2023 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2022 - 05/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 04/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2017
2	Disease Progression 01/2022 - 01/2011
2	Cholangiocarcinoma 01/2021 - 01/2019
2	Adenocarcinoma of Lung 06/2019 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 06/2010
2	Osteoporosis 09/2015 - 04/2006
2	Ovarian Neoplasms (Ovarian Cancer) 11/2014 - 12/2006
1	Hypersensitivity (Allergy) 02/2024
1	Venous Thromboembolism 01/2024
1	Hemorrhage 01/2024
1	Albuminuria 12/2023

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2004
11	EnzymesIBA 10/2022 - 06/2004
9	AntioxidantsIBA 04/2022 - 06/2004
8	Uncoupling Protein 2IBA 01/2020 - 01/2013
7	CarcinogensIBA 01/2015 - 01/2009
6	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 09/2011
6	Superoxide DismutaseIBA 04/2014 - 01/2003
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
5	LipopolysaccharidesIBA 01/2022 - 01/2015
5	AntibodiesIBA 09/2015 - 01/2002
4	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 11/2016 - 01/2003
4	Pyruvate KinaseIBA 01/2015 - 09/2011
3	ORALIT (ORS)IBA 12/2023 - 05/2018
3	Blood Glucose (Blood Sugar)IBA 02/2023 - 07/2018
3	DioxinsIBA 01/2021 - 01/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 05/2005
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 07/2014
3	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2019 - 10/2005
3	NF-kappa B (NF-kB)IBA 10/2015 - 10/2005
3	Monoclonal AntibodiesIBA 06/2015 - 09/2002
3	shikoninIBA 01/2015 - 01/2014
3	ProtandimIBA 01/2011 - 01/2009
2	AnticoagulantsIBA 01/2024 - 01/2023
2	CarbonIBA 11/2023 - 11/2014
2	fibrin fragment D (D-dimer)IBA 11/2023 - 06/2017
2	Endocrine DisruptorsIBA 11/2023 - 01/2023
2	bis(4-hydroxyphenyl)sulfoneIBA 01/2023 - 03/2022
2	tyramine-deoxysorbitolIBA 03/2022 - 03/2022
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 12/2021 - 02/2020
2	Halogenated Diphenyl EthersIBA 01/2021 - 10/2018
2	AcidsIBA 01/2021 - 01/2019
2	Polychlorinated Biphenyls (PCBs)IBA 01/2021 - 01/2018
2	Indicators and Reagents (Reagents)IBA 02/2020 - 05/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2019
2	genipinIBA 01/2020 - 01/2019
2	Gemcitabine FDA Link 01/2020 - 01/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019 - 04/2006
2	withaferin AIBA 10/2019 - 11/2016
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2019 - 08/2012
2	Okadaic AcidIBA 06/2019 - 01/2014
2	CeramidesIBA 01/2019 - 11/2014
2	RNA Precursors (Precursor, mRNA)IBA 01/2019 - 11/2014
2	Mutant Proteins (Protein, Mutant)IBA 01/2019 - 11/2014
2	LipidsIBA 01/2018 - 10/2017
2	Activating Transcription Factor 3IBA 12/2017 - 10/2017
2	AnionsIBA 11/2017 - 01/2017
2	LigandsIBA 06/2017 - 01/2011
2	CytokinesIBA 02/2016 - 09/2015
2	Small Interfering RNA (siRNA)IBA 02/2016 - 10/2010
2	Interleukin-6 (Interleukin 6)IBA 10/2015 - 01/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2015 - 04/2006
2	Mitochondrial Uncoupling ProteinsIBA 06/2015 - 01/2011
2	Phosphotransferases (Kinase)IBA 06/2015 - 01/2014
2	Free RadicalsIBA 06/2015 - 05/2008
2	Protein Isoforms (Isoforms)IBA 01/2015 - 09/2011
2	Tamoxifen FDA LinkGeneric 04/2014 - 04/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2011 - 06/2010
2	Antineoplastic Agents (Antineoplastics)IBA 06/2010 - 04/2006
2	CarbohydratesIBA 02/2007 - 09/2002
2	Peptides (Polypeptides)IBA 02/2007 - 09/2002
2	Proteasome InhibitorsIBA 12/2006 - 10/2005
2	Acetates (Acetic Acid Esters)FDA Link 08/2006 - 05/2005
1	Phosphates (Orthophosphate)IBA 02/2024
1	Ethylene Oxide (Oxirane)IBA 12/2023
1	Hemoglobins (Hemoglobin)IBA 12/2023

Therapy/Procedure

18	Therapeutics 11/2023 - 10/2005
3	Immunotherapy 01/2021 - 01/2013
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2006
3	Chemoprevention 01/2015 - 01/2009
2	Radiotherapy 01/2021 - 10/2005